科研之友
微信
新浪微博
Facebook
分享链接
摘要
Dicoma anomala Sond (Asteraceae) is widely incorporated as a treatment for diabetes mellitus among the Basotho tribe of the Eastern Free State Province, South Africa. The study examined the antidiabetic effect of the plant via the in vitro inhibition of alpha-amylase, and alpha-glucosidase as well as against streptozotocin (STZ)-induced diabetic Wistar rats. The in vitro antidiabetic activity of the plant is via the inhibition of alpha-amylase, and alpha-glucosidase using water, ethanol, hydro-ethanol and methanol extracts. The effect of administration of aqueous root extract of Dicoma anomala (AQRED) at 125, 250, and 500 mg/kg bodyweight (b.w.) on water consumption, feed intake, body-weight, blood glucose, carbohydrate-metabolizing enzymes, antioxidant enzymes, glycosylated haemoglobin and lipid profiles was determined in STZ (60 mg/kg b.w.)-induced diabetic rats with comparison with glibenclamide (5 mg/kg b.w.). While all the extracts of D. anomala showed activity against alpha-amylase and a-glucosidase, water extract revealed the most effective inhibition with an IC50 of 51.90 and 27.41 mu g/mL respectively. The water extract displayed competitive and non-competitive inhibitors of alpha-amylase and alpha-glucosidase respectively. AQRED reversed towards normal control the elevated food/water intake, blood glucose levels, lipid peroxidation, lipid profiles, glycosylated haemoglobin and activities of gluconeogenesis enzymes with a concomitant decrease in body-weight, activities of enzymatic antioxidants, glycolytic enzymes as well as the high-density lipoprotein-cholesterol level brought-about by STZ administration. The result of our findings proved the antihyperglycaemic activity of the plant and therefore validates the folkloric usage of the herb.
- 出版日期2017-9
